Contact
Please use this form to send email to PR contact of this press release:
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
TO:
Please use this form to send email to PR contact of this press release:
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
TO: